Found: 4
Select item for more details and to access through your institution.
Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01943
- By:
- Publication type:
- Article
The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of BMI‐1 as an essential tumour gene.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 877, doi. 10.1111/bjh.16595
- By:
- Publication type:
- Article
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 261, doi. 10.3390/cancers11020261
- By:
- Publication type:
- Article
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0281-2
- By:
- Publication type:
- Article